The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens – STAT
The post The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens appeared first on Links Medicus.
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance – The Lancet Infectious Diseases
The post Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis appeared first on Links Medicus.
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv News release: RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19 Commentary: Expert reaction to preprint from the RECOVERY trial on the antibiotic azithromycin in patients hospitalised with COVID-19, reporting no benefit – Science Media Centre […]
The post [Preprint] RECOVERY trial: Azithromycin does not improve outcomes in hospitalized patients with COVID-19 appeared first on Links Medicus.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine Commentary: Baricitinib plus remdesivir shows promise for treating COVID-19 – NIH News Releases Commentary on Twitter Not sure how to interpret a trial for a drug plus Remdesivir vs Remdesivir alone when you don't know if Remdesivir works. @NEJM today […]
The post Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19 appeared first on Links Medicus.
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial – JAMA Commentary: Idiopathic pulmonary fibrosis: Co-trimoxazole therapy did not prevent disease progression – MedicalResearch Commentary on Twitter In this RCT oral co-trimoxazole (TMP-SMX) did not reduce […]
The post Randomized trial: Trimethoprim-Sulfamethoxazole does not benefit patients with moderate and severe idiopathic pulmonary fibrosis appeared first on Links Medicus.
Coronavirus Vaccine Update With Anthony Fauci – JAMA
The post Video: Coronavirus vaccine update with Anthony Fauci appeared first on Links Medicus.
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19 – Scientific Reports
The post A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19 – corticosteroid treatment is not recommended for patients with mild or moderate COVID-19 appeared first on Links Medicus.
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis – PLOS One
The post Meta-analysis: Efficacy and harms of remdesivir for the treatment of COVID-19. “Until stronger evidence emerges, we cannot conclude that remdesivir is efficacious for treating COVID-19”. appeared first on Links Medicus.
|
Effect of a Lower vs Higher Positive End-Expiratory Pressure Strategy on Ventilator-Free Days in ICU Patients Without ARDS: A Randomized Clinical Trial – JAMA Editorial: Searching for the Optimal PEEP in Patients Without ARDS: High, Low, or in Between? Video: Effect of Lower vs Higher PEEP Strategy on Ventilator-Free Days in ICU Patients Without ARDS […]
The post Randomized trial: Among patients in the ICU receiving invasive ventilation, a strategy with lower PEEP was noninferior to a strategy using higher PEEP appeared first on Links Medicus.